Stoke Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.61 | -$0.61 | -$0.61 |
| Q2 2024 | 2 | -$0.55 | -$0.55 | -$0.55 |
| Q3 2024 | 6 | -$0.59 | -$0.49 | -$0.52 |
| Q4 2024 | 2 | -$0.55 | -$0.55 | -$0.55 |
| Q1 2025 | 5 | -$0.57 | -$0.57 | -$0.57 |
| Q2 2025 | 5 | -$0.56 | -$0.56 | -$0.56 |
| Q3 2025 | 5 | -$0.58 | -$0.58 | -$0.58 |
| Q4 2025 | 5 | -$0.57 | -$0.57 | -$0.57 |
Stoke Therapeutics, Inc. Earnings Date And Information
Stoke Therapeutics, Inc. last posted its earnings results on Wednesday, August 7th, 2024. The company reported $-0.46 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $0.11. The company had revenue of 4.83 M for the quarter and had revenue of 8.78 M for the year. Stoke Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.38 diluted earnings per share) and currently has a price-to-earnings ratio of -6.77. Stoke Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Stoke Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/07/2024 | Q2 2024 | -$0.57 | -$0.46 | 0.11 | $3.70 M | $4.83 M |
| 05/06/2024 | Q1 2024 | -$0.60 | -$0.57 | 0.03 | $4.22 M | |
| 03/25/2024 | Q4 2023 | -$0.60 | $2.80 M | |||
| 11/07/2023 | Q3 2023 | -$0.65 | -$0.55 | 0.1 | $3.64 M | $3.31 M |
| 08/07/2023 | Q2 2023 | -$0.65 | -$0.69 | -0.04 | $3.44 M | $-2,481,000 |
| 05/04/2023 | Q1 2023 | -$0.70 | -$0.43 | 0.27 | $5.15 M | |
| 03/06/2023 | Q4 2022 | -$0.72 | -$0.56 | 0.16 | $3.27 M | |
| 11/14/2022 | Q3 2022 | -$0.69 | -$0.61 | 0.08 | $2.72 M | $2.91 M |
| 08/08/2022 | Q2 2022 | -$0.70 | -$0.59 | 0.11 | $2.64 M | $3.23 M |
| 05/10/2022 | Q1 2022 | $0.61 | -$0.65 | -1.26 | $3.00 M | |
| 03/10/2022 | Q4 2021 | -$0.62 | -$0.66 | -0.04 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.58 | -$0.61 | -0.03 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.49 | -$0.60 | -0.11 | $0 | |
| 05/10/2021 | Q1 2021 | -$0.44 | -$0.46 | -0.02 | $0 | |
| 03/09/2021 | Q4 2020 | -$0.43 | -$0.44 | -0.01 | $0 | |
| 11/12/2020 | Q3 2020 | -$0.42 | -$0.41 | 0.01 | $0 | |
| 08/10/2020 | Q2 2020 | -$0.36 | -$0.39 | -0.03 | $0 | |
| 05/15/2020 | Q1 2020 | -$0.37 | -$0.34 | 0.03 | $0 | |
| 03/23/2020 | Q4 2019 | -$0.31 | $0 | |||
| 11/12/2019 | Q3 2019 | -$0.29 | -$0.26 | 0.03 | $0 |
Stoke Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Stoke Therapeutics, Inc.'s earnings date?
Stoke Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
Did Stoke Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Stoke Therapeutics, Inc. (:STOK) reported $-0.46 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.11.
-
How can I listen to Stoke Therapeutics, Inc.'s earnings conference call?
The conference call for Stoke Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Stoke Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Stoke Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Stoke Therapeutics, Inc. generate each year?
Stoke Therapeutics, Inc. (:STOK) has a recorded annual revenue of $8.78 M.
-
How much profit does Stoke Therapeutics, Inc. generate each year?
Stoke Therapeutics, Inc. (:STOK) has a recorded net income of $8.78 M. Stoke Therapeutics, Inc. has generated $-2.38 earnings per share over the last four quarters.
-
What is Stoke Therapeutics, Inc.'s price-to-earnings ratio?
Stoke Therapeutics, Inc. (:STOK) has a price-to-earnings ratio of -6.77 and price/earnings-to-growth ratio is -0.71.
